Raltegravir. In HIV-infected in children at least 2 years of age. Only after prior treatment failure


Prescrire International 23(152): 206

2014


ISSN/ISBN: 1167-7422
PMID: 25325117
Document Number: 677336
The first integrase inhibitor to be approved for children; antiretroviral effect similar to that observed in adults in treatment failure; no first-line evaluation.

Document emailed within 1 workday
Secure & encrypted payments